Lindsay Hughes, EVP of Healthcare, Ruder Finn

Lindsay Hughes, EVP of Healthcare, Ruder Finn

NEW YORK, May 11, 2022 /PRNewswire/ -- Leading global communications agency, Ruder Finn, today announced that healthcare industry veteran, Lindsay Hughes, has joined the agency as Executive Vice President of the New York Healthcare practice.

With 17 years of agency-side marketing and communications experience, Hughes has led Agency of Record engagements for some of the world's largest companies and brands. She brings expertise in brand reputation management and executive communications and has executed innovative marketing solutions for companies such as AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, AMAG Pharmaceuticals and Johnson & Johnson Medical Device enterprises. Hughes's experience ranges across several therapeutic areas including oncology, respiratory, immunology, cardiovascular and women's health.

Reporting directly to Christie Anbar, Managing Director of Healthcare, Hughes will help to shape and build the firm's Healthcare practice by providing leadership on marquee accounts, unlocking new opportunities for strategic partnerships, and delivering breakthrough communications that provide meaningful impact for all stakeholders.

"Our Healthcare practice is on a powerful trajectory for expansion worldwide," said Anbar. "Lindsay is a perfect partner to help us maximize current and new business opportunities, and ultimately, fortify our organic growth strategy. With her history in providing best-in-class experiences for some of the most reputable healthcare brands, I have no doubt that her capabilities will help the practice soar to new heights."

"Ruder Finn is a force to be reckoned with in the Healthcare communications industry, and I am thrilled to join a team so dedicated to excellence in this space," said Hughes. "I look forward to working alongside the team as we build and execute a vision for the future that is aimed at uncovering what's next."

About Ruder Finn  

Ruder Finn is one of the world's largest independent global communications and creative agencies. Founded in 1948, Ruder Finn has defined and redefined PR for more than 70 years, shaping communications that help move industry-defining brands, companies, and leaders from what's now to what's next. Headquartered in New York, Ruder Finn provides clients with bold communications strategies based on a global perspective and localized market knowledge that redefine leadership, reimagine the marketplace, and rethink customer experiences around a shared sense of purpose. The agency is organized around four core areas of expertise: Health & Wellness, Technology & Innovation, Purpose-Driven Leadership and Commerce, each fueled by predicted analytics, breakthrough creative, and 360 digital engagement. Specialty practices include RF Relate, RFx Creative Studios, RF Internal Customer Experience (ICX) and RF TechLab. Ruder Finn has offices across 4 continents including the U.S., Asia, Europe, and the Middle East. Wholly owned agencies within Ruder Finn Group include: Ruder Finn Inc., RLA Collective, SPI Group, Osmosis Films, jacobstahl, RF Bloom and Bloom Health. For more information visit

Media Contact: 

Isabelle Lee

Cision View original content to download multimedia:

SOURCE Ruder Finn

Recommended For You

Originally published on the TownNews Content Exchange.

You must be logged in to react.
Click any reaction to login.

(0) comments

Welcome to the discussion.

Transparency. Your full name is required.
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article. And receive photos, videos of what you see.
Don’t be a troll. Don’t be a troll. Don’t post inflammatory or off-topic messages, or personal attacks.

Thank you for reading!

Please log in, or sign up for a new account and purchase a subscription to read or post comments.

To subscribe, click here. Already a subscriber? Click here.